Diversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement ...

India's commercial vehicle (CV) sales aim to cross 1 million units in FY26 after two slow years. Improved freight rates, ...

CVS Health (CVS) stock in focus as Glenview Capital trims a third of its stake after the company's Q1 2025 earnings beat.

CVS Health has raised its full-year profit forecast, driven by robust performance across its sectors and strategic ... CVS anticipates improved financial health amid growing healthcare demands from ...

CVS Health President and CEO. The company’s Health Care Benefits segment saw adjusted operating income surge to $1.99 billion from $732 million a year ago, driven by favorable prior-year development ...

CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my ...

(Reuters) -Eli Lilly on Thursday downplayed CVS Health (NYSE:CVS)’s decision to drop the company’s obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of ...

(Reuters) - CVS Health raised its full-year profit forecast on Thursday following strong performance across its businesses, signaling an early recovery after a series of troubles hit the healthcare ...

Entrance to a CVS Pharmacy in Manhattan. (Photo by ... More Erik McGregor/LightRocket via ) LightRocket via Getty Imag ...

Shareholders of tier one lender, Fidelity Bank, have applauded the board and management of the bank for delivering an outstanding performance ... top 3 dividend-paying financial institutions ...